Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Quantitative evaluation of L-(methyl-C-11) methionine uptake in tumor using positron emission tomography

Journal Article · · Journal of Nuclear Medicine; (USA)
OSTI ID:5024932

Tumor uptake of L-(methyl-{sup 11}C)methionine (({sup 11}C)Met) was assessed in six patients with brain tumors and three patients with lung cancer using positron emission tomography (PET). In arterial plasma samples taken at 5, 15, 30, and 60 min after injection, a fraction of ({sup 11}C)Met was measured using high performance liquid chromatography in individual patients. Employing curve fitting, a history of ({sup 11}C)Met activity was obtained as an input function. By means of sequential PET scannings and graphic analysis, uptake rate and distribution volume of ({sup 11}C)Met in tumor tissue were calculated. In two studies irreversible uptake into the tumors was not seen when total plasma {sup 11}C activity was used as the input; however when ({sup 11}C)Met plasma activity was used, definite irreversible uptake was seen, indicating tumor viability. In other studies, up to 24% underestimation of uptake rate was found. The present results demonstrated the importance of measuring ({sup 11}C)Met in plasma for quantitative assessment of in vivo amino acid metabolism in tumors.

OSTI ID:
5024932
Journal Information:
Journal of Nuclear Medicine; (USA), Journal Name: Journal of Nuclear Medicine; (USA) Vol. 30:11; ISSN 0161-5505; ISSN JNMEA
Country of Publication:
United States
Language:
English